In prostate cancer, for instance, IFITM3 facilitated tumor progression and bone metastasis via TGF-β-Smads-MAPK pathway [18]; as IFITM3 was proposed to serve as a PIP3 scaffold protein to amplify PI3K signaling in B cells [23]. The gene discussed is IFITM3; the disease is neoplasm.